BJS Academy
>
Randomized clinical ...
>
Pembrolizumab versus...
Normal View
Dyslexic View
Facebook
Twitter
Linkedin
Email
Copy Link
Copy embeded link
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
17 May 2022
Randomized clinical trials
General
Home
View
Normal view
Dyslexic view
Info
Share
Facebook
Twitter
Linkedin
Email
Copy Link
Copy embeded link
Copied!